Comparison of Different Nanosuspensions as Potential Ophthalmic Delivery Systems for Ketotifen Fumarate

Saieede Soltani ^1,2, Parvin Zakeri-Milani ^3,4, Mohammad Barzegar-Jalali ⁴, Mitra Jelvehgari ^1,4 *

Cited by CrossRef: 18

1- Bielory L, Schoenberg D. Emerging Therapeutics for Ocular Surface Disease. Curr Allergy Asthma Rep. 2019;19(3) [Crossref]

2- Alvarez-Lorenzo C, Anguiano-Igea S, Varela-García A, Vivero-Lopez M, Concheiro A. Bioinspired hydrogels for drug-eluting contact lenses. Acta Biomaterialia. 2019;84:49 [Crossref]

3- Chen M, Xu X, Shu G, Lu C, Wu J, Lv X, Song J, Wu F, Chen C, Zhang N, Du Y, Wang J, Xu M, Fang S, Weng Q, Zhu Y, Huang Y, Zhao Z, Du Y, Ji J. Multifunctional Microspheres Dual-Loaded with Doxorubicin and Sodium Bicarbonate Nanoparticles to Introduce Synergistic Trimodal Interventional Therapy. ACS Appl Bio Mater. 2021;4(4):3476 [Crossref]

4- Chen H, Jin Y, Sun L, Li X, Nan K, Liu H, Zheng Q, Wang B. Recent Developments in Ophthalmic Drug Delivery Systems for Therapy of Both Anterior and Posterior Segment Diseases. Colloid and Interface Science Communications. 2018;24:54 [Crossref]

5- Souto E, Dias-Ferreira J, López-Machado A, Ettcheto M, Cano A, Camins Espuny A, Espina M, Garcia M, Sánchez-López E. Advanced Formulation Approaches for Ocular Drug Delivery: State-Of-The-Art and Recent Patents. Pharmaceutics. 2019;11(9):460 [Crossref]

6- Wang C, Pang Y. Nano-based eye drop: Topical and noninvasive therapy for ocular diseases. Advanced Drug Delivery Reviews. 2023;194:114721 [Crossref]

7- Franco P, De Marco I. Controlled-release antihistamines using supercritical antisolvent process. The Journal of Supercritical Fluids. 2021;171:105201 [Crossref]

8- Jaiswal P, Mishra A, Kesharwani D, Das Paul S. Overview on Ocular Drug Delivery through Colloidal Nano-Suspension. RJPT. 2023;:1533 [Crossref]

9- Polat H, Bozdağ Pehlivan S, Özkul C, Çalamak S, Öztürk N, Aytekin E, Fırat A, Ulubayram K, Kocabeyoğlu S, İrkeç M, Çalış S. Development of besifloxacin HCl loaded nanofibrous ocular inserts for the treatment of bacterial keratitis: In vitro, ex vivo and in vivo evaluation. International Journal of Pharmaceutics. 2020;585:119552 [Crossref]

10- Abdelhaleem Ali A, Abo El-Enin H. In-vitro/in-vivo evaluation of Paclitaxel Freeze-Dried micellar nanoparticles intended for buccal delivery. Journal of Drug Delivery Science and Technology. 2021;62:102424 [Crossref]

11- Fathi-Karkan S, Amiri Ramsheh N, Arkaban H, Narooie-Noori F, Sargazi S, Mirinejad S, Roostaee M, Sargazi S, Barani M, Malahat Shadman S, Althomali R, Rahman M. Nanosuspensions in ophthalmology: Overcoming challenges and enhancing drug delivery for eye diseases. International Journal of Pharmaceutics. 2024;658:124226 [Crossref]

12- Pınar S, Oktay A, Karaküçük A, Çelebi N. Formulation Strategies of Nanosuspensions for Various Administration Routes. Pharmaceutics. 2023;15(5):1520 [Crossref]

13- Singh R, Liu L, Yung A, Anchouche S, Mittal S, Blanco T, Dohlman T, Yin J, Dana R. Ocular redness – II: Progress in development of therapeutics for the management of conjunctival hyperemia. The Ocular Surface. 2021;21:66 [Crossref]

14- Liu L, Chen Y, Lu D. Overview of Recent Advances in Nano-Based Ocular Drug Delivery. IJMS. 2023;24(20):15352 [Crossref]

15- Berillo D, Kadyrgaliev B. Review of Recent Advances in the Use of Drug Delivery Systems in Ophthalmology. rev and adv in chem. 2023;13(3):167 [Crossref]